Yuko Mishima^1,2, Yuji Mishima², Masahiro Yokoyama¹, Noriko Nishimura¹, Yoshiharu Kusano¹, Norihito Inoue¹, Hideki Uryu¹, Takanori Fukuta¹, Yuko Shirouchi¹, Kiyohiko Hatake³, Yasuhito Terui^1,2 (1.Hematol Oncol, The Cancer Institute Hospital of JFCR, Tokyo, Japan, 2.Cancer chemotherapy center, Clinical Chemotherapy, Tokyo, Japan, 3.Hematology, International University of Health and Welfare School of Medicine)

Takashi Kanamori^1,2, Masashi Sanada², Masaki Ri¹, Hiroo Ueno³, Dai Nishijima², Takahiko Yasuda², Sho Aoki¹, Arisa Asano¹, Takuto Tachita¹, Shiori Kinoshita¹, Tomoko Narita¹, Asahi Ito¹, Shigeru Kusumoto¹, Atsushi Inagaki⁴, Yuta Masuda⁵, Nobuhiko Kobayashi⁶, Yusuke Shiozawa^3,7, Kenichi Yoshida³, Masahiro Nakagawa³, Yasuhito Nanya³, Yuichi Shiraishi⁸, Kenichi Chiba⁹, Hiroko Tanaka⁹, Hirokazu Komatsu¹, Satoru Miyano⁹, Hiroshi Handa⁵, Seishi Ogawa^3,10,11, Shinsuke Iida¹ (1.Department of Hematology and Oncology, Nagoya City University, Nagoya, Japan, 2.Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 3.Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan, 4.Hematology and Oncology, Nagoya City West Medical Center, Nagoya, Japan, 5.Graduate School of Health Sciences, Gunma University, Maebashi, Japan, 6.Department of Medicine and Clinical Science, Gunma University, Maebashi, Japan, 7.Department of. Pediatrics, University of Tokyo, Tokyo, Japan, 8.Division of Cellular Signaling, National Cancer Center Research Institute, Japan, 9.Human Genome Center, Insti. of Med. Science, University of Tokyo, Tokyo, Japan, 10.WPI-ASHBi, Kyoto University, Kyoto, Japan, 11.Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden)

Shigeki Hirabayashi^1,2, Hiroyuki Yamazaki², Kotaro Shirakawa², Akifumi Takaori², Hideya Kawaji^1,3, Yasuhiro Murakawa^1,4 (1.RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan, 2.Department of Hematology and Oncology, Kyoto University, Kyoto, Japan, 3.RIKEN Preventive Medicine and Diagnosis Innovation Program, Kanagawa, Japan, 4.iFOM, The FIRC Institute of Molecular Oncology, Milan, Italy)

Shuku Sato, Wataru Kamata, Satomi Okada, Yotaro Tamai (Division of hematology, Shonan Kamakura General Hospital, Kamakura, Japan)

Ryosuke Kinoshita¹, Mariko Ishibashi², Mika Sunakawa¹, Koichi Inokuchi¹, Hiroshi Handa³, Makoto Sasaki⁴, Norio Komatsu⁴, Yoichi Imai⁵, Norina Tanaka⁶, Junji Tanaka⁶, Sakae Tanosaki⁷, Shigeki Ito⁸, Atsushi Isoda⁹, Morio Matsumoto⁹, Michiaki Koike¹⁰, Toshio Asayama¹, Yasuko Kuribayashi¹, Keiichi Moriya¹, Hideto Tamura¹ (1.Division of Hematology, Department of Medicine, Nippon Medical School, 2.Department of Microbiology and Immunology, Nippon Medical School, 3.Department of Hematology, Gunma University, 4.Division of Hematology, Juntendo University School of Medicine, 5.Department of Hematology and Oncology, IMSUT Hospital, 6.Department of Hematology, Tokyo Women's Medical University, 7.Department of Hematology, The Fraternity Memorial Hospital, 8.Department of Hematology and Oncology, Iwate Medical University, 9.Department of Hematology, National Hospital Organization Shibukawa Medical Center, 10.Department of Hematology, Juntendo University Shizuoka Hospital)

Kentaro Narita¹, Takeshi Yoroidaka², Hiroyuki Takamatsu², Shinji Nakao², Kosei Matsue¹ (1.Division of Hematology/Oncology, Kameda Medical Center, Chiba, Japan, 2.Department of Hematology, Faculty of Medicine, Kanazawa University, Japan)